TS
GILD icon

Triglav Skladi’s Gilead Sciences GILD Stock Holding History

Triglav Skladi’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.02M Hold
16,000
– – 0.11% 99
2026
Q1 		$2.23M Sell
16,000
-4,387
-22% -$614K 0.16% 81
2025
Q4 		$2.5M Buy
20,387
+4,387
+27% +$533K 0.16% 83
2025
Q3 		$1.78M Hold
16,000
– – 0.12% 84
2025
Q2 		$1.77M Hold
16,000
– – 0.13% 85
2025
Q1 		$1.79M Hold
16,000
– – 0.15% 77
2024
Q4 		$1.48M Buy
+16,000
New +$1.44M 0.12% 89

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Triglav Skladi's GILD Position: Q2 2026 in Review

Triglav Skladi held its Gilead Sciences (GILD) position steady in Q2 2026 at 16,000 shares worth $2.02M. The position accounts for 0.11% of the portfolio, ranked #99.

Triglav Skladi first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.5M in Q4 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Triglav Skladi held 16,000 shares of Gilead Sciences worth $2.02M as of Q2 2026.
  • Triglav Skladi left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.11% of Triglav Skladi's portfolio in Q2 2026, its #99 holding.
  • Triglav Skladi first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • Triglav Skladi's Gilead Sciences position peaked at $2.5M in Q4 2025.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Triglav Skladi's 13F filing for Q2 2026, filed 11 Aug 2026.